The current study focused on the effects of chrysophanol on cell motility and cancer metabolism in CRC via the KITENIN and ErbB4 pathways, and the results provide a new perspective on the previously demonstrated anticancer effects of chrysophanol. Here, ERBB4 is linked to colorectal carcinoma.